Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Cadila Healthcare Limited
WARNING LETTER
•Cadila Healthcare Limited•December 6, 2014

Cadila Healthcare Limited – FDA Warning Letter, Dec 6, 2014

Record Details

The FDA issued a Warning Letter to Cadila Healthcare Limited following inspections in August-September and December 2014 at two facilities in Ahmedabad, India (FEI 3002984011 and FEI 3006595385). The inspections revealed significant violations of CGMP regulations for finished pharmaceuticals (21 CFR Parts 210 and 211) and deviations from CGMP for active pharmaceutical ingredients (APIs), rendering their drugs adulterated.

At FEI 3002984011, violations included inadequate investigation of out-of-specification (OOS) results for warfarin sodium, a narrow therapeutic index drug, with recurring quality problems despite previous inspections and a recall. The firm also failed to adequately investigate consumer complaints regarding product mix-ups, did not file Field Alert Reports (FARs) promptly, and had deficient complaint handling procedures.

At FEI 3006595385, violations included failure to establish written procedures to control API processing steps, leading to repeated failing results for related compound analysis without root cause identification. The firm also failed to control computerized systems to prevent unauthorized data access or changes, with evidence of deleted electronic records and shared login credentials. Additionally, employees used "unofficial notebooks" for CGMP activities, and duplicate records with discrepancies were found, indicating poor documentation practices and a lack of corporate quality assurance.

Cadila's responses were

Company
Cadila Healthcare Limited
Inspection date
December 6, 2014
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Thomas J. Cosgrove
View Company Profile

ID · 75ba1232-49eb-4b08-8422-d76b712bc274

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121 CFR 211.19221 CFR 211.198(a)21 CFR 211.198(b)(2)FD&C Act 501(a)(2)(B)FD&C Act 801(a)(3)21 U.S.C. 381(a)(3)21 U.S.C. 356C(a)(1)

Full citation text and observation details available on the Dashboard.

Other documents for Cadila Healthcare Limited
  • WARNING_LETTER - 2019-05-03May 3, 2019
  • 483 - 2017-03-01March 1, 2017

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Cadila Healthcare Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.